As truly pan-European requirements for product development and registration have become a reality, there is an accompanying need for a consistent, homogenous and harmonised approach for the monitoring of adverse drug reactions and the sharing of safety information across the EU. The various EU Pharmacovigilance guidelines intend to achieve this. This seminar will provide an interpretation of the new regulations and detailed guidance on how SARs should be handled, the requirements of PSURs and Pharmacovigilance Inspections. This will be reinforced by interactive case-based discussions and workshops. In addition, an overview of some of the future issues in respect of global harmonisation and electronic communication will be considered. If you require any further information regarding this event please contact Andrea James on: andrea.james@management-forum.co.uk(source: www.management-forum.co.uk)